fig3
![MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy](https://image.oaes.cc/0f958f15-a9fe-4504-970f-db41e2c05fbd/3140.fig.3.jpg)
Figure 3. Disease free survival (DFS). The DFS at time of operation according to A, circulating microRNA-126 (cir-miRNA-126), B circulating epidermal growth factor-like domain 7 (cir-EGFL7), and C the combined estimate
Figure 3. Disease free survival (DFS). The DFS at time of operation according to A, circulating microRNA-126 (cir-miRNA-126), B circulating epidermal growth factor-like domain 7 (cir-EGFL7), and C the combined estimate
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/